Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKAE Immunotherapy with Salvage Chemotherapy in Relapsed/Refractory Acute Leukemia
NCT02074657Phase 2Completed
- Sponsor
- Hospital Universitario La Paz
- Start
- Apr 2014
- Primary completion
- Sep 2016
- Modality
- Lymphokine-Activated Killer Cells, CAR-NK Cells
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical IL-15–activated expanded NK cells in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Hospital Universitario La Paz. Started Apr 2014; status: completed.
02
Drugs
haploidentical IL-15–activated expanded NK cells
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02074657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02074657.